[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"product:biogeom":3},{"id":4,"name":5,"slug":6,"slogan":7,"description":8,"organization":9,"images":10,"avatar_url":11,"image_url":12,"website_url":13,"status":14,"build_by":15,"categories":16,"stats":26,"upload_relationship":32,"create_at":33,"update_at":34,"owner_id":29,"upload_user_id":35,"reviewer_id":36,"video_info":37,"prerelease_cover_url":38,"scheduled_publish_at":37,"user_scheduled":39,"emoji_reacts":40,"tag":37,"user_star":39},2558,"百奥几何","biogeom","以生成式 AI，解码生命几何","{\"type\": \"doc\", \"content\": [{\"type\": \"paragraph\", \"content\": [{\"text\": \"百奥几何是一家生成式 AI 驱动的生物科技公司，致力于“让生成式 AI 设计下一代药物”。公司核心产品 GeoBiologics 是面向抗体发现与蛋白设计的新一代 AI 平台，底层由自研蛋白质生成式大模型 GeoFlow V3 与高通量湿实验闭环平台共同驱动，覆盖结构建模、分子优化、从头设计、成药性预测和实验验证等关键环节。\", \"type\": \"text\"}]}, {\"type\": \"paragraph\", \"content\": [{\"text\": \"GeoBiologics 能够从靶点结构、目标表位和可开发性约束出发，生成候选抗体、VHH、小蛋白或蛋白工程方案，并结合湿实验结果持续迭代模型，帮助研发团队从传统“筛选候选物”转向“设计候选物”。平台可用于抗体从头设计、抗体亲和力优化、抗体人源化、黏度\u002F表达量\u002F稳定性\u002F聚集性等成药性预测，以及疫苗蛋白、酶和其他功能蛋白的工程改造。\", \"type\": \"text\"}]}, {\"type\": \"paragraph\", \"content\": [{\"text\": \"相比依赖大规模文库筛选和反复试错的传统研发流程，百奥几何通过“计算设计-实验验证-模型学习”的干湿闭环，提升早期命中率，缩短发现周期，并减少不必要的实验筛选。附件案例显示，平台已完成多个 VHH 从头设计、IgG 设计、小蛋白设计、抗体亲和力优化和疫苗蛋白工程项目，并在部分项目中实现约 3 周完成计算设计与湿实验验证的交付节奏。\", \"type\": \"text\"}]}, {\"type\": \"paragraph\", \"content\": [{\"text\": \"产品适用于创新药企、Biotech、CRO\u002FCDMO、科研机构和合成生物学企业，尤其适合需要快速获得高质量候选分子、优化抗体亲和力与可开发性、探索难成药靶点、构建差异化知识产权或加速早期药物发现的团队。合作方式包括 SaaS 平台授权、私有化部署\u002F一体机方案、定制化项目合作，以及面向未来创新管线的共同开发。\", \"type\": \"text\"}]}, {\"type\": \"paragraph\", \"content\": [{\"text\": \"常见问题：\", \"type\": \"text\"}]}, {\"type\": \"orderedList\", \"attrs\": {\"type\": null, \"start\": 1}, \"content\": [{\"type\": \"listItem\", \"content\": [{\"type\": \"paragraph\", \"content\": [{\"text\": \"平台是否只做抗体？不只。百奥几何以抗体发现为核心优势，同时覆盖 VHH、IgG、小蛋白、疫苗蛋白工程和更广泛的蛋白设计场景。\", \"type\": \"text\"}]}]}, {\"type\": \"listItem\", \"content\": [{\"type\": \"paragraph\", \"content\": [{\"text\": \"是否包含实验验证？可以。平台不仅提供 AI 设计和预测，也可结合高通量湿实验验证，形成从设计到筛选再到优化的闭环。\", \"type\": \"text\"}]}]}, {\"type\": \"listItem\", \"content\": [{\"type\": \"paragraph\", \"content\": [{\"text\": \"是否适合已有候选分子的优化？适合。平台可用于亲和力、稳定性、表达量、聚集性和人源化等多目标优化。\", \"type\": \"text\"}]}]}, {\"type\": \"listItem\", \"content\": [{\"type\": \"paragraph\", \"content\": [{\"text\": \"是否支持企业级合作？支持。可根据客户需求提供平台授权、私有化部署、定制模型训练、结构分析、湿实验验证和联合管线开发等合作模式。\", \"type\": \"text\"}]}]}]}, {\"type\": \"paragraph\"}]}","北京生物几何科技有限公司","https:\u002F\u002Fwatcha.tos-cn-beijing.volces.com\u002Fprod\u002Fuser\u002Fuploads\u002F10070497_1783909254_4d980932-b451-497a-8372-94f748eb9b4b.png;https:\u002F\u002Fwatcha.tos-cn-beijing.volces.com\u002Fprod\u002Fuser\u002Fuploads\u002F10070497_1783909254_e28de920-dc3d-41e2-ad24-4a00e50cb077.png;https:\u002F\u002Fwatcha.tos-cn-beijing.volces.com\u002Fprod\u002Fuser\u002Fuploads\u002F10070497_1783909254_14b649d5-8125-4b5e-b16b-8b1a5fd20cf9.png;https:\u002F\u002Fwatcha.tos-cn-beijing.volces.com\u002Fprod\u002Fuser\u002Fuploads\u002F10070497_1783909254_178d3101-9067-46eb-ba0c-a5b9ebb22ea0.png;https:\u002F\u002Fwatcha.tos-cn-beijing.volces.com\u002Fprod\u002Fuser\u002Fuploads\u002F10070497_1783909254_9519e160-0a11-4861-a710-a8c9db6fa2cb.png","https:\u002F\u002Fwatcha.tos-cn-beijing.volces.com\u002Fprod\u002Fuser\u002Fuploads\u002F10070497_1783907636_30716384-8945-45d4-a9f2-358b06a1b469.png","https:\u002F\u002Fwatcha.tos-cn-beijing.volces.com\u002Fprod\u002Fuser\u002Fuploads\u002F10070497_1783909260_b73155c7-ec76-4d4b-b65c-9f1cfe89ae4d.png","https:\u002F\u002Fwww.biogeom.com\u002Fzh\u002F","PUBLISHED",[],[17,20,23],{"id":18,"name":19},8,"知识管理",{"id":21,"name":22},9,"科研辅助",{"id":24,"name":25},15,"3D 生成",{"upvotes":27,"stars":28,"review_count":27,"reply_count":29,"score":30,"update_at":31},1,2,0,2.0654329147389294,"2026-07-26T17:50:05.943Z","CREATOR","2026-07-13T02:24:23.568Z","2026-07-13T06:53:48.528Z",10070497,10004627,null,"",false,{"reacts":41},[]]